The Risk of Endophthalmitis Following Intravitreal Injection in the DRCR.net Laser-Ranibizumab-Triamcinolone Clinical Trials

OBJECTIVE: To report the incidence of endophthalmitis following intravitreal injection using a standardized procedure. METHODS: Intravitreal injections of preservative-free triamcinolone acetonide or ranibizumab were performed in two Diabetic Retinopathy Clinical Research Network prospective, random...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bhavsar, Abdhish R., Googe, Joseph M., Stockdale, Cynthia R., Bressler, Neil M., Brucker, Alexander J., Elman, Michael J., Glassman, Adam R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2874253/
https://ncbi.nlm.nih.gov/pubmed/20008710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archophthalmol.2009.304
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados